Researchers at Le Bonheur Children’s Hospital and the University of Tennessee Health Science Center announced results from a clinical trial of a drug shown to safely reduce the viral load and clinical illness of healthy adult volunteers intranasally infected with respiratory syncytial virus (RSV).
The post Breakthrough in RSV Research to Help Infected Children appeared first on UTHSC News.